Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1987-6-5
pubmed:abstractText
The influence of antibody and complement on the polymorphonuclear leukocytic uptake and killing of type II group B streptococci (GBS) was examined with 11 adult sera and three type II strains possessing the trypsin-resistant and trypsin-sensitive components (II/TR+TS) of the "c" (formerly Ibc) protein or two type II strains lacking both components (II/no c) of the c protein. All tested sera mediated a greater than 1 log10 reduction in colony-forming units (CFUR) of a type II/no c strain, even in the absence of measurable type-specific antibody (less than 1.08 micrograms/ml), but only 5 of 11 mediated a greater than 1 log10 CFUR of any type II/TR/TS strain, even in the presence of moderate levels of type-specific antibody. The classical pathway of complement activation appeared to be more important than the alternative pathway, and even absorbed or immunoglobulin G (IgG)-depleted serum (IgG, 10 mg/dl) mediated a greater than 1 log10 CFUR without magnesium ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (magnesium EGTA) chelation. Chelation with magnesium EGTA reduced the CFUR in 4 of 11 test sera and greatly reduced the CFUR in absorbed or IgG-depleted sera for type II/no c strains. Despite variation in the phagocytic killing of two representative strains of type II GBS, both strains were well phagocytized, as measured by radiolabeled bacterial uptake or electron microscopy. This study suggested that poorly killed type II/TR+TS GBS were easily phagocytized but apparently resisted intracellular killing.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-101462, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-1097573, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-3519791, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-376729, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-3882857, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-3891622, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-3901889, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-396335, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-6192144, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-6201506, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-6341233, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-6341485, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-6346797, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-6348093, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-6376652, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-6379061, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-6387034, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-6423540, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-6991426, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-7028073, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-7028075, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-7033908, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-7035495, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-7037956, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-7048229, http://linkedlifedata.com/resource/pubmed/commentcorrection/3552996-845484
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0019-9567
pubmed:author
pubmed:issnType
Print
pubmed:volume
55
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1243-51
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.
pubmed:publicationType
Journal Article, Comparative Study, In Vitro, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't